Aeglea Biotherapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $21M | 557k | 37.93 |
| 2023-09-30 | $242k | 20k | 12.25 |